Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications
Turkish Journal of Ophthalmology · 2025
DOI: 10.4274/tjo.galenos.2025.19940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Ophthalmology, 2025. Verfasst von Merve Özbek und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences Türkiye, Beyoğlu Göz Training and Research Hospital, Clinic of Ophthalmology, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Visual Acuity, Retinal Telangiectasis, Macula Lutea, Disease Management. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
To evaluate the long-term progression of macular telangiectasia type 2 (MacTel) using a standardized classification system and to assess the incidence, progression, and management strategies of complications such as macular neovascularization (MNV) and macular hole (MH). Materials and Methods: This retrospective study analyzed the medical records of patients diagnosed with MacTel at a tertiary referral center in Türkiye from January 2004 to February 2025. Patients with a minimum follow-up of 3 years and no confounding macular pathologies were included. Data collection included best corrected visual acuity (BCVA), multimodal imaging (optical coherence tomography [OCT], fundus autofluorescence, fluorescein angiography), and demographic variables. Disease severity was classified using the MacTel Classification System developed by Chew et al. Longitudinal changes in BCVA and OCT parameters were statistically analyzed.
Results
A total of 184 eyes from 94 patients (mean age: 63.89±9.98 years; mean follow-up: 79.27±50.69 months) were included. A significant decline in BCVA was observed (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Health Sciences Türkiye, Beyoğlu Göz Training and Research Hospital, Clinic of Ophthalmology, İstanbul, Türkiye.
ORCID-Profile: Merve Özbek, Özgür Artunay, Rümeysa Koçak, İlker Hoşver, Metehan Şimşek
Zitieren
APA
Özbek, M., Artunay, Ö., Koçak, R., Hoşver, İ., & Şimşek, M. (2025). Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications. Turkish Journal of Ophthalmology. https://doi.org/10.4274/tjo.galenos.2025.19940
Vancouver
Özbek M, Artunay Ö, Koçak R, Hoşver İ, Şimşek M. Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications. Turkish Journal of Ophthalmology. 2025. doi:10.4274/tjo.galenos.2025.19940
BibTeX
@article{zbek2025,
author = {Özbek, Merve and Artunay, Özgür and Koçak, Rümeysa and Hoşver, İlker and Şimşek, Metehan},
title = {Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications},
journal = {Turkish Journal of Ophthalmology},
year = {2025},
doi = {10.4274/tjo.galenos.2025.19940}
}
EUVIMED